Alyeska Investment Group, L.P. M Dx Health Sa Transaction History

Alyeska Investment Group, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 14, 2023	SELL	$3.07 - $4.2 $983,766 - $1.35 Million	-320,445 Reduced 53.41%	279,555 $953,000
Q1 2023 May 15, 2023	BUY	$2.61 - $7.15 $1.57 Million - $4.29 Million	600,000 New	600,000 $1.94 Million

9.5K

Ticker MDXH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,288,100
Market Cap $34.7M
Description
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which prov...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.